An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen
about
Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a.Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis.Can one size fit all? Towards a universal anthrax vaccine.Intranasal immunization with dry powder vaccines.
P2860
Q35221206-DA36EA7C-9CD9-4326-9BCD-8D165AB6C6EBQ35853440-4F631A8A-C221-4557-B34A-B03E41F1977AQ36978423-E57F9CB7-199A-4870-A0BE-15704331B362Q37067254-6E9B1006-C555-40AF-B8C0-66F380021EDAQ37545021-4D35BFE0-C07D-4CAE-8B51-D398591DB9ECQ37627897-C3848DDD-6F7D-4BA6-9627-DFB24FE26F8FQ37722981-4B7AFD70-F766-4A5E-9079-A5A7DF2AD626Q47162390-48EE18F4-1022-4FD2-AD5D-45E512CBE603Q47250394-A67550D4-0487-498A-8E47-8D7439AE5B89Q47584590-08C90396-2035-4F21-A8D7-FF1776E4BC16
P2860
An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@ast
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@en
type
label
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@ast
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@en
prefLabel
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@ast
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@en
P2093
P2860
P356
P1476
An adenovirus-vectored nasal v ...... thrax in a single-dose regimen
@en
P2093
De-chu C Tang
Edward Jex
Gloria S Sivko
Jianfeng Zhang
Kent R Van Kampen
Stanley Goldman
Tsungwei Feng
P2860
P356
10.1128/CVI.00280-12
P50
P577
2012-10-24T00:00:00Z